In Section A, contributors will receive diverse doses and schedules of oral ABBV-744 pill to identify Safe and sound dosing program. Further members are going to be enrolled in the recognized monotherapy dosign regimen. In Section B, contributors will get oral ruxolitinib and ABBV-744 is going to be presented as https://abbv-744inacutemyeloidleu46891.tokka-blog.com/32195519/clinical-trial-recruitment-for-abbv-744-study-fundamentals-explained